Close Menu

NEW YORK – A study published recently in Clinical Chemistry has demonstrated a lower-than expected accuracy in procalcitonin (PCT) testing for diagnosing pneumonia patients presenting with dyspnea, or labored breathing, supporting a widespread opinion among clinical laboratorians that clinicians should not rely too heavily on the biomarker to decide whether to prescribe antibiotics for pneumonia.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.